Redox potential studies based on scan-rate analysis of the diffusional control and dft calculations of the schiff base [(E)-4-amino-3-((3,5-di-tert-butyl-2-hydroxybenzylidene)amino) benzoic acid] |
Rosaly Morales-GuevaraI,II; Dayán Páez-HernándezI; Manuel GacitúaIII,IV,V,*; Juan A. FuentesVI; Alexander CarreñoI,VII,*
I. Laboratorio de Síntesis Organometálica, Centro de Nanociencias Aplicadas (CANS), Facultad de Ciências Exactas, Universidad Andres Bello, República 330, 8370186 Santiago, Chile Received: 11/02/2023 Schiff bases are diverse organic compounds with an azomethine structure (-C=N-), holding potential in both chemistry and biology. They serve as catalysts, stabilizers, and exhibit various biological activities. The molecular structure of Schiff bases influences their biological properties, including antimicrobial effects. Redox-active compounds with more negative potentials tend to be more effective against microbes. In one of our recent studies, we explored the antimicrobial properties of two Schiff bases derivatives, SB-1 ((E)-4-amino-3-((3,5-di-tert-butyl-2-hydroxybenzylidene)amino) and SB-2 ((E)-2-((4-nitrobenzilidene)amino)aniline). SB-1 showed antibacterial activity against certain Gram-positive bacteria, while SB-2 did not. The difference in their cyclic voltametric profiles, especially SB-1's more negative reduction potential, prompted us to carry out further characterizations, including scan-rate studies, solvent analysis, and computational calculations. We found that SB-1, which presents a stable intramolecular hydrogen bond, undergoes irreversible oxidation, likely at the -NH2 group, and a quasi-reversible reduction via an intramolecular reductive coupling of the (-C=N-) azomethine group, supported by orbital theoretical calculations. This research sheds light on the potential applications of Schiff bases in antimicrobial contexts, guided by their redox properties and structure. INTRODUCTION Schiff bases are a diverse group of organic compounds characterized by an azomethine structure (-C=N-), featuring a double bond linking carbon and nitrogen atoms.1,2,3 Numerous Schiff bases have been synthesized, incorporating many combinations of alkyl or aryl substituents,4,5 thereby inspiring extensive research in the fields of chemistry and biology.6,7,8,9,10 Schiff bases display a wide range of chemical applications, such as their utilization as catalysts, stabilizers, and intermediates in organic synthesis.11,12,13,14 Moreover, they exhibit significant biological potential, manifesting antiproliferative, antiinflammatory, antiviral, antimalarial, antifungal, antibacterial, and antipyretic activities.15-20 It has been reported21-24 that the molecular structure of Schiff bases can influence biological activities, including antimicrobial properties. Additionally, the structure determines other properties, such as affinity for various targets in biological systems, stability in biological media, and cellular uptake. These factors plausibly contribute to the observed biological activities, particularly the antimicrobial capacity. Therefore, conducting studies to enhance the characterization of these Schiff bases can significantly contribute to a well understanding of the molecular mechanisms underlying these biological activities. Redox-active of natural compounds or their structural derivatives have the ability to inhibit pathogen growth by disrupting cellular redox homeostasis or the function of redox-sensitive cellular components. This disruption of redox balance has been associated with antimicrobial activity, suggesting a correlation between the redox potential and antimicrobial effectiveness.25,26 In this sense, the electrochemistry has been gaining attention as a tool to characterize compounds exhibiting antimicrobial properties and other biological activities.27 In our recent study,24 we investigated the antimicrobial activity of two Schiff bases derivatives, SB-1 [(E)-4-amino-3-((3,5-di-tert-butyl-2-hydroxybenzylidene)amino) benzoic acid], see Scheme 1, and SB-2 [(E)-2-((4-nitrobenzilidene)amino)aniline], against Gram-positive bacteria. SB-1 demonstrated antibacterial effects against Staphylococcus aureus, Enterococcus faecalis, and Bacillus cereus, similar to chloramphenicol, while SB-2 exhibited no effect on these bacteria. Given the observed differences in the cyclic voltametric profiles of these two Schiff bases, with SB-1 displaying a more negative reduction potential (SB-1 RedI(irr): −0.90 V; SB-2 RedII(rev): −0.80 V) and a more positive oxidation potential compared to SB-2 (SB-1 OxI(irr): 1.23 V; SB-2 OxI(irr): 0.94 V), we conducted a complementary characterization of SB-1. This included a scan-rate study to determine whether these processes are diffusion-controlled. Additionally, we employed previously untested deuterated solvents with varying polarities (chloroform, acetonitrile, and acetone) for further characterization of the SB-1 structure. Fourier transform infrared-attenuated total reflectance (ATR-FTIR) and ultraviolet visible spectrophotometry (UV-Vis) techniques were also utilized. Furthermore, quantum chemistry calculations were performed to corroborate the redox potentials and generate electron density maps, clarifying the regions where reductions or oxidations occur in the carbon backbone.
Scheme 1. Chemical structure of [(E)-4-amino-3-((3,5-di-tert-butyl-2-hydroxybenzylidene)amino) benzoic acid] benzoic acid (SB-1)
Quantum chemistry theory All the work presented in this study was conducted within the relativistic density functional theory framework using the Amsterdam density functional (ADF) code.28 The molecular structures were fully optimized using the hybrid B3LYP functional,29,30 and the standard Slater-type orbital (STO) basis set with triple-ζ quality and double plus polarization functions (TZ2P) for all atoms.31,32 Frequency analysis was performed to obtain thermodynamic parameters used to determine the redox potentials. Additionally, solvation energies were estimated using a conductor-like screening model (COSMO),33,34 with the parameters specific to acetonitrile. The second part of the calculations aimed to determine the equilibrium oxidation and reduction potentials.35,36 To establish the computational protocol for estimating the redox potentials, reference to the thermodynamic cycle,37,38,39,40,41 depicted in Figures 1, 2 proved to be valuable. The standard Gibbs free energies (in acetonitrile) were obtained by performing calculations in both gas phase and solution for the reduced and oxidized species. The gas phase free energies were derived from single-point energy calculations, followed by frequency calculations employing Equation 1:
Figure 1. Thermodynamic free energy cycle employed to calculate the redox potential of the (SB-1)/(SB-1)+1 pair. ΔG0s (redox, gas) and ΔG0s (redox, acetonitrile) represent the free energy change for the redox process in the gas phase and in the presence of acetonitrile, respectively. Furthermore, ΔG0s (FR) and ΔG0s (FO) denote the solvation free energy change for the reduced and oxidized forms
Figure 2. Thermodynamic free energy cycle employed to calculate the redox potential for (SB-1)−1/(SB-1) pair. ΔG0s (redox, gas) and ΔG0s (redox, acetonitrile) represent the free energy change for the redox process in the gas phase, and in the presence of acetonitrile, respectively. Additionally, ΔG0s (FR) and ΔG0s (FO) denote the solvation free energy change for the reduced and oxidized form
The standard absolute redox potential (E0) can be calculated using the Equation 2: In the given Equation 2, n represents the number of electrons consumed or generated in the specific half-reaction, and F denotes the Faraday constant. This thermodinamic model establishes a direct connection between the changes in free energy in the condensed phase related to reduction or oxidation and the corresponding processes in the gas phase. Furthermore, in order to determine the free energy associated with ionization or electron attachment at 298 K, it is essential to calculate the thermal contributions to the free energy at 298 K. Taking this into consideration, the remaining link between the gas and the condensed phase is defined by the difference in solvation free energies between the species oxidized and reduced involved in the respective processes. The calculated absolute free energy of reduction or oxidation represents the generation or consumption of a free electron. However, in practical terms, free electrons do not directly participate in reactions. Instead, they are consumed or generated by another half-reaction, respectively.
EXPERIMENTAL The Fourier transform infrared-attenuated total reflectance (ATR-FTIR) spectra were acquired using a FT-IR Spectrometer Spectrum Two (PerkinElmer, Chile). The 1H NMR and 13C NMR spectra of SB-1 were recorded on a Bruker AVANCE III HD-400 (FONDEQUIP EQM120021, Unidad Central de Instrumentación, Facultad de Química y de Farmacia, Pontifícia Universidad Católica de Chile, Chile) operating at 400 MHz and maintained at 25 °C. All samples were dissolved in deuterated chloroform, acetone, or acetonitrile, with tetramethylsilane serving as the internal reference. Values of Δ in ppm and J in Hz. For the electrochemical experiments, see Supplementary Material.42,43 Materials The reagents employed in the synthesis were commercially available from Aldrich (Aldrich, Chile) and were used as received without additional purification. Chemical The (E)-4-amino-3-((3,5-di-tert-butyl-2-hydroxybenzylidene) amino)benzoic acid (SB-1) was prepared by direct condensation of primary amine with their corresponding substituent benzaldehyde, according to a previously described method (see Scheme 1S).6,8,24 Further information can be found in the Supplemetary Material.
RESULTS AND DISCUSSION Synthesis and characterizations of SB-1 The (E)-4-amino-3-((3,5-di-tert-butyl-2-hydroxybenzylidene) amino) benzoic acid (referred to as SB-1) was synthesized through the direct condensation of amino benzoic acid and the corresponding phenol aldehyde (Scheme 1S in the Supplementary Material). Previously, we reported the structure of SB-1, which was determined using NMR analysis in deuterated dimethyl sulfoxide (DMSO). The analysis revealed the presence of an intramolecular hydrogen bond (IHB) between the N atom of the Schiff base and the -OH group of the phenolic ring, providing stability.24 The significance of the IHB has been demonstrated in similar Schiff bases, influencing both their photophysical properties and biological activities.6,8,41,44,45 In light of this, our aim was to further characterize the stability of the IHB in SB-1 by examining its behavior in previously untested deuterated solvents with varying dielectric constants, namely chloroform (ε = 4.81), acetone (ε = 20.7), and acetonitrile (ε = 37.5). We sought to determine whether solvent polarity could influence the IHB. To achieve this, we conducted 1H and 13C NMR analyses at 25 °C. Notably, the key signals corresponding to the -OH and -NH2 groups, as well as the protons of the azomethine moiety, consistently appeared at approximately 13.30, 5.79, and 8.84 ppm, respectively, across all solvents (see Figures 1S to 4S in the Supplementary Material). Table 1 provides the principal proton assignments. In less stable IHBs, interactions with polar solvents like acetone or acetonitrile typically result in destabilization due to intermolecular interactions. Consequently, a shift in the assigned signal positions in the 1H NMR spectrum is expected. Conversely, no changes are anticipated in more stable IHBs, regardless of the solvent used. This approach has been previously employed to assess IHB stability in other pyridine Schiff bases.41,46 Confirming the stability of the IHB, its peak remained consistently at the same position (approximately 13.30 ppm) in all the solvents tested, regardless of their dielectric constants. Furthermore, the proton associated with the azomethine group (-CH=N-), H4, exhibited a singlet peak at approximately 8.96-8.68 ppm.
The signals assigned to the tert-butyl groups appear at 1.47 and 1.28 ppm. The aromatic protons of aromatic rings appear at 7.50-6.70 and 8.60-8.00 ppm, respectively. The 13C NMR was recorded in deuterated chloroform and acetonitrile, showing the azomethine carbon around 170 ppm in agreement with similar Schiff bases(see Figures 5S and 6S in the Supplementary Material).8,47 On the other hand, the absorption spectra of SB-1 were studied in three organic solvents of increasing polarity (chloroform, acetonitrile, and DMSO) at room temperature. In the presence of chloroform, acetonitrile, or DMSO, we observed that SB-1 presented two intense absorption bands around 281 and 377 nm (Table 2 and Figure 7S in the Supplementary Material). The band around 281 nm corresponds to the π → π* of the aromatic rings, by analogy with similar Schiff bases compounds.6,48,49 The band around 377 nm was assigned to a combination of π → π* and n → π* ligand transitions (which involves the IHB). In the case of SB-1, we observed no significant shifts in the IHB band, independent of the solvent used.
SB-1 exhibits no luminescent properties plausibly due to the rigidity of the structure, which substantially reduces the vibronic relaxation.50,51 This agrees with the change in the molecule's configuration when excitation occurs in similar systems containing the azomethine group.41 The ATR-FTIR spectrum was used to confirm the SB-1 structure. Two bands at 3475 and 3379 cm−1 were assigned to the stretching vibrations mode (asymmetric and symmetric mode) of vNH (primary amino group) (Figure 8S in the Supplementary Material). These assignments are congruent with previously reported studies.6,8,52 It is important to remark that, due to the ATR-FTIR limitations,53 the bands assigned to the -OH appeared to be thinner than the bands obtained with the KBr pellet. Other authors54 reported broader bands in the 3500-3000 cm−1 range due to the stretching vOH group engaged in the IHB. Nevertheless, we could not observe those bands in our ATR-FTIR spectrum, probably due to the overlapping with the bands assigned to νNH. We also assigned other bands observed at 2960 and 2867 cm−1 as νOH or νC-OH and νC-H, respectively. Other remarkable bands were observed at 1608 and 1559 cm−1, assigned as νHC=N (azomethine) and νC=C, respectively. It is worth underlining that the azomethine group is usually assigned to around 1640 cm−1. The lower values observed for νHC=N can be explained by the interaction of the azomethine and the hydroxyl groups, both involved in the IHB, as previously reported for similar Schiff bases.6,8,41 These results: 1H NMR, 13C NMR, UV-Vis, and ATR-FTIR together corroborate the high stability of IHB and, more importantly, the purity of the SB-1 powder that was subsequently used for electrochemical tests. Scan-rate study The cyclic voltammetry for SB-1 was already performed in anhydrous CH3CN under an argon atmosphere. Several oxidation and reduction processes were identified by direct analysis of the cyclic voltammograms.24 In this work, we conducted a complementary characterization of SB-1 using a scan-rate study to determine whether these processes are diffusion-controlled. For SB-1, a scan-rate study was performed (Figure 3), where one oxidation at 1.23 V (irreversible) and one reduction at −0.90 V (quasi-reversible) were observed. Table 3 summarizes the description of signals, and Table 4 shows the scan-rate study.
Figure 3. Scan-rate study for SB-1. Interphase: Pt|1.0 × 10−2 M of compound + 1.0 × 10−1 M TBAPF6 in anhydrous CH3CN
SB-1 profile presents at least one irreversible oxidation process, as previously described for similar Schiff bases with an intramolecular hydrogen bond.41,46 The nature of this irreversible oxidation is typically ascribed to an oxidation taking place somewhere at the aminobenzoic ring, most likely at the -NH2 moiety.6 On the other hand, the quasi-reversible reduction may be attributed to an intramolecular reductive coupling of the azomethine group, which involved a self-protonation reaction.55,56 As discussed below, molecular models and the frontier orbitals HOMO-LUMO were carried out to complement these assignations. Quantum chemical results In order to better understand the nature of the redox processes described above, we performed theoretical calculations using the thermodynamic cycle. We found 1.67 and −0.90 V for the oxidation and reduction process, respectively, of SB-1, reproducing the same experimental trend (Table 3). On the other hand, we calculated the probability of finding an electron at a specific location around the aromatic rings or the azomethine group using electron density plots (Figure 4).
Figure 4. Electron density for SB-1: HOMO (blue) and LUMO (red)
We observed that HOMO is mainly distributed in the benzoic acid ring, where oxidation is most likely to occur. Besides, the considerable potential difference in oxidation peaks obtained with calculations could be explained by the electron withdrawal influence of the carboxylic acid group on SB-1, which increases the energy (potential) required to oxidize the amine group. In the case of LUMO, it is predominantly distributed between the two aromatic rings, showing a preference for the azomethine group. As stated above, the reduction processes in this kind of compound are found in the azomethine group,41,57 which is presumably related to the reduction of the N-H bond distance (H of the intramolecular hydrogen bond) found in the reduced form in the molecule in the calculations. To complement this analysis, an electron density difference map was performed, showing electrons' different occupied regions in the SB-1 skeleton (Figure 5). The isosurface map between HOMO and LUMO allowed us to better observe the oxidation at the amino group (benzoic acid ring) and the reduction at the azomethine group, corroborating the previous calculations. These results agree with the experimental electrochemical discussion scan-rate study above.
Figure 5. Electron density difference map between the HOMO and LUMO orbitals for SB-1
CONCLUSIONS In this report, we provided a further characterization of SB-1 regarding the structure and the redox potential. We found that the intramolecular hydrogen bond in SB-1 presented a high stability, even in solvents with increased polarity. Furthermore, we determined the electrochemical profile of SB-1, providing further details with a scan-rate study. The SB-1 profile demonstrated an irreversible oxidation process, likely occurring at the pyridine ring's -NH2 group, while its reduction is associated with an intramolecular reductive coupling of the azomethine group, featuring quasi-reversibility due to a self-protonation reaction. Molecular models, frontier orbital calculations using the thermodynamic cycle and the electron density between HOMO and LUMO were utilized to corroborate these findings. SUPPLEMENTARY MATERIAL Complementary material for this work is available at http://quimicanova.sbq.org.br/, as a PDF file, with free access.
ACKNOWLEDGMENTS This work was funded by FONDECYT 1230917 and Núcleo UNAB DI-01-22/NUC. A. Carreño thanks to Núcleo UNAB-DI-02-22/NUC, J. A. Fuentes thanks to FONDECYT 1220584, and R. Morales-Guevara thanks the Ph.D. fellowship ANID 21210811. We thank Juan Manuel Ortega Martínez (Fondecyt Regular 1230917) for his help with the English translation.
REFERÊNCIAS 1. Omidi, S.; Kakanejadifard, A.; RSCAdv. 2020, 10, 30186. [Crossref] 2. da Silva, C. M.; da Silva, D. L.; Modolo L. V.; Alves, R. B.; de Resende, M. A.; Martins, C. V. B.; de Fátima, A.; J. Adv. Res. 2011, 2, 1. [Crossref] 3. Carreño, A.; Vega, A.; Zárate, X.; Schott, E.; Gacitúa, M.; Valenzuela, N.; Preite, M.; Manriquez, J. M.; Chávez, I.; Quim. Nova 2014, 37, 584. [Crossref] 4. Tan, X. J.; Wang, D.; Hei, X. M.; Yang, F. C.; Zhu, Y. L.; Xing, D. X.; Ma, J. P.; Acta Crystallogr., Sect. C: Struct. Chem. 2020, 76, 44. [Crossref] 5. Sharma, S.; Dubey, G.; Sran, B. S.; Sharma, M.; Kaur, V.; Kaur, S.; Bharatam, P. V.; Hundal, G.; ChemistrySelect 2022, 7, 1. [Crossref] 6. Carreño, A.; Rodriguez, L.; Páez-Hernández, D.; Martin-Transaco, R.; Zúñiga, C.; Oyarzún, D.; Gacitúa, M.; Schott, E.; Arratia-Pérez, R.; Fuentes, J. A.; Front. Chem. 2018, 6, 312. [Crossref] 7. Luo, Y.; Wang, J.; Zhang, B.; Guan, Y.; Yang, T.; Li, X.; Xu, L.; Wang, J.; Yo, Z.; J. Coord. Chem. 2020, 73, 1765. [Crossref] 8. Carreño, A.; Zúñiga, C.; Páez-Hernández, D.; Gacitúa, M.; Polanco, R.; Otero, C.; Arratia-Pérez, R.; Fuentes, J. A.; New J. Chem. 2018, 42, 8851. [Crossref] 9. Luna, I.; Neves, W. W.; de Lima Neto, R. G.; Albuquerque, A. P. B.; Pitta, M. G. R.; Rêgo, M. J. B. M.; Neves, R. P.; Scotti, M. T.; Mendonça Júnior, F. J. B.; J. Braz. Chem. Soc. 2021, 32, 1017. [Crossref] 10. Sahu, S. K.; Azam, M. A.; Banerjee, M.; Acharrya, S.; Behera, C. C.; Si, S.; J. Braz. Chem. Soc. 2008, 19, 963. [Crossref] 11. Jezierska, A.; Tolstoy, P. M.; Panek, J. J.; Filarowski, A.; Catalysts 2019, 9, 909. [Crossref] 12. Gebrezgiabher, M.; Bayeh, Y.; Gebretsadik, T.; Gebreslassie, G.; Elemo, F.; Thomas, M.; Linert, W.; Inorganics 2020, 8, 66. [Crossref] 13. Rigamonti, L.; Zardi, P.; Carlino, S.; Demartin, F.; Castellano, C.; Pigani, L.; Ponti, A.; Ferretti, A. M.; Pasin, A.; Int. J. Mol. Sci. 2020, 21, 7882. [Crossref] 14. Dogaheh, S. G.; Barbero, S.; Barrientos, J.; Janczak, J.; Soleimannejad, J.; Sañudo, E. C.; Int. J. Mol. Sci. 2020, 21, 3574. [Crossref] 15. Ullah, H.; Rahim, F.; Taha, M.; Hussain, R.; Tabassum, N.; Wadood, A.; Nawaz, M.; Mosaddik, A.; Imran, S.; Wahab, Z.; Abbas Miana, G.; Kanwal; Khan, K. M.; Arabian J. Chem. 2020, 13, 4904. [Crossref] 16. Prasad, S.; Radhakrishna, V.; Ravi, T. K.; Arabian J. Chem. 2019, 12, 3943. [Crossref] 17. Venugopala, K. N.; Kandeel, M.; Pillay, M.; Deb, P. K.; Abdallah, H. H.; Mahomoodally, M. F.; Chopra, D.; Antibiotics 2020, 9, 559. [Crossref] 18. Nastasa, C.; Vodnar, D. C.; Ionut, I.; Stana, A.; Benedec, D.; Tamaian, R.; Oniga, O.; Tiperciuc, B.; Int. J. Mol. Sci. 2018, 19, 222. [Crossref] 19. Rafiq, K.; Khan, M.; Muhammed, N.; Khan, A.; Rehman, N. U.; Al-Yahyaei, B. E. M.; Khiat, M.; Halim, S. A.; Shah, Z.; Csuk, R.; Al-Harrasi, A.; Med. Chem. Res. 2021, 30, 712. [Crossref] 20. Aslam, M.; Anis, I.; Mehmood, R.; Iqbal, L.; Iqbal, S.; Khan, I.; Chishti, M. S.; Perveen, S.; Med. Chem. Res. 2015, 25, 109. [Crossref] 21. Weng, Q.; Yi, J.; Chen, X.; Luo, D.; Wang, Y.; Wang, Y.; Sun, W.; Kang, J.; Han, Z.; ACS Omega 2020, 5, 24864. [Crossref] 22. Wang, D.; Li, H.; Sun, S.; Xu, Y.; Org. Lett. 2020, 22, 3361. [Crossref] 23. Reimann, M. J.; Salmon, D. R.; Horton, J. T.; Gier, E. C.; Jefferies, L. R.; ACS Omega 2019, 4, 2874. [Crossref] 24. Gacitúa, M.; Carreño, A.; Morales-Guevara, R.; Páez-Hernández, D.; Martinez-Araya, J. I.; Araya, E.; Preite, M.; Otero, C.; Rivera-Zaldivar, M. M.; Silva, A.; Fuentes, J. A.; Int. J. Mol. Sci. 2022, 23, 2553. [Crossref] 25. Kim, J. H.; Cheng, L. W.; Land, K. M.; Gruhlke, M. C. H.; Front. Microbiol. 2021, 12, 758750. [Crossref] 26. Brzoza, P.; Godlewska, U.; Borek, A.; Morytko, A.; Zegar, A.; Kwiecinska, P.; Zabel, B. A.; Osyczka, A.; Kwitniewski, M.; Cichy, J.; Antioxidants 2021, 10, 446. [Crossref] 27. Nesmerak, K.; Mini-Rev. Med. Chem. 2020, 20, 1341. [Crossref] 28. te Velde, G.; Bickelhaupt, F. M.; Baerends, E. J.; Guerra, C. F.; van Gisbergen, S. J. A.; Snijders, J. G.; Ziegler, T.; J. Comput. Chem. 2001, 22, 931. [Crossref] 29. Raghavachari, K.; Theor. Chem. Acc. 2000, 103, 361. [Crossref] 30. Al-Busaidi, I. J.; Rashid Ilmi, R.; Dutra, J. D. L.; Oliveira, W. F.; Haque, A.; Al Rasbi, N. K.; Marken, F.; Raithby, P. R.; Khan, M. S.; Dalton Trans. 2021, 50, 1465. [Crossref] 31. Páez-Hernández, D.; Murillo-López, J. A.; Arratia-Pérez, R.; Organometallics 2012, 31 , 6297. [Crossref] 32. Van Lenthe, E.; Baerends, E. J.; J. Comput. Chem. 2003, 24, 1142. [Crossref] 33. Klamt, A.; Jonas, V.; Bürger, T.; Lohrenz, J. C. W.; J. Phys. Chem. A 1998, 102, 5074. [Crossref] 34. Lange, A. W.; Herbert, J. M.; J. Chem. Phys. 2011, 134, 204110. [Crossref] 35. Jaque, P.; Marenich, A. V.; Cramer, C. J.; Truhlar, D. G.; J. Phys. Chem. C 2007, 111, 5783. [Crossref] 36. Winget, P.; Weber, E. J.; Cramer, C. J.; Truhlar, D. G.; Phys. Chem. Chem. Phys. 2000, 2, 1231. [Crossref] 37. Sebens, C. T.; Foundations of Physics 2021, 51, 75. [Crossref] 38. Psciuk, B. T.; Schlegel, H. B.; J. Phys. Chem. B 2013, 117, 9518. [Crossref] 39. Sundstrom, E. J.; Xinzheng Yang, X.; Thoi, V. S.; Karunadasa, H. I.; Chang, C. J.; Long, J. R.; Head-Gordon, M.; J. Am. Chem. Soc. 2012, 134, 5233. [Crossref] 40. Rojas-Poblete, M.; Carreño, A.; Gacitúa, M.; Páez-Hernández, D.; Rabanal-Leóne, W. A.; Arratia-Pérez, R.; New J. Chem. 2018, 42, 5471. [Crossref] 41. Carreño, A.; Gacitúa, M.; Páez-Hernández, D.; Polanco, R.; Preite, P.; Fuentes, J. A.; Mora, G.; Chávez, I.; Arratia-Pérez, R.; New J. Chem. 2015, 39, 7822. [Crossref] 42. Diaz, F. R.; Pardo, M. A.; Gacitúa, M. A.; del Valle, M. A.; J. Chil. Chem. Soc. 2020, 65, 5023. [Crossref] 43. del Valle, M. A.; Int. J. Electrochem. Sci. 2019, 14, 8131. [Crossref] 44. Morales-Guevara, R.; Fuentes, J. A.; Páez-Hernández, D.; Carreño, A.; RSC Adv. 2021, 11, 37181. [Crossref] 45. Morales-Guevara, R.; Fuentes, J. A.; Páez-Hernández, D.; Carreño, A.; J. Phys. Chem. A 2022, 126, 8997. [Crossref] 46. Carreño, A.; Páez-Hernández, D.; Cantero-López, P.; César Zúñiga, C.; Nevermann, J.; Ramirez-Osorio, A.; Gacitúa, M.; Oyarzún, P.; Sáez-Cortez, F.; Rubén Polanco, R.; Otero, C.; Fuentes, J. A.; Molecules 2020, 25, 2741. [Crossref] 47. Malik, M. A.; Lone, S. A.; Gull, P.; Dar, O. A.; Wani, M. Y.; Ahmad, A.; Hashmi, A. A.; Med. Chem. 2019, 15, 648. [Crossref] 48. Reddy, K. R.; Raghu, A. V.; Jeong, H. M.; Siddaramaiah; Des. Monomers Polym. 2012, 12, 109. [Crossref] 49. Zoubi, W. A.; Kandil, F.; Org. Chem.: Curr. Res. 2012, 1, 1. [Crossref] 50. Gopal, V. R.; Reddy, A. M.; Rao, V. J.; J. Org. Chem. 2002, 60, 7966. [Crossref] 51. Karatsu, T.; Kitamura, A.; Zeng, H.; Arai, T.; Sakuragi, H.; Tokumaru, K.; Bull. Chem. Soc. Jpn. 1995, 68, 920. [Crossref] 52. Oketani, R.; Takahashi, H.; Hoquante, M.; Brandel, C.; Cardinael, P.; Coquerel, G.; J. Mol. Struct. 2019, 1184, 36. [Crossref] 53. Grdadolnik, J.; Acta Chim. Slov. 2002, 49, 631. [Link] accessed in April 2024 54. Hansen, P. E.; Molecules 2021, 26, 2409. [Crossref] 55. Venkittapuram, P.; Dhandapani, M.; Suyambulingam, J.; Subramanian, C.; J. Serb. Chem. Soc. 2020, 85, 215. [Crossref] 56. Zolezzi, S.; Spodine, E.; Decinti, A.; Polyhedron 2002, 21, 55. [Crossref] 57. Tümer, M.; J. Coord. Chem. 2007, 60, 2051. [Crossref] |
On-line version ISSN 1678-7064 Printed version ISSN 0100-4042
Qu�mica Nova
Publica��es da Sociedade Brasileira de Qu�mica
Caixa Postal: 26037
05513-970 S�o Paulo - SP
Tel/Fax: +55.11.3032.2299/+55.11.3814.3602
Free access